Opinion of the Transparency Council – methotrexatum
At its meeting on 16 August 2022 the Transparency Council adopted Opinion No. 130/2022 on the active substance methotrexatum for the indications: sarcoidosis; granulomatous lung diseases in cases other than those specified in the SmPC.
Publication with the minutes of the Transparency Council meeting